Thenyldiamine

DB16022ApprovedWithdrawnSmall molecule

Thenyldiamine is an ingredient in products indicated to treat rhinitis caused by the common cold.

Chemical structure of Thenyldiamine
Formula / weight
C14H19N3S · 261.39 g/mol (avg)
First approval
Canada, 1992
Code names
202-098-2

Resolves to

Compound
UNIIE4U52363JECAS91-79-2ChEMBLCHEMBL2107485
Clinical / RWD
RxNorm38025
Structure
InChIKeyRCGYDFVCAAKKNG-UHFFFAOYSA-NSMILESCN(C)CCN(CC1=CSC=C1)C1=CC=CC=N1

What you can answer from here — as of August 30, 2026

9ContraindicationsEach with its own population and attribute set
Sign in
4Marketed productsAcross 2 countries and 3 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Thenyldiamine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In